Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Aug-24 9:13 PM View:  | Nexgel, Inc. (NXGL) | 23-Aug-24 | Purchase | 10,000 | $2.50 | $25,000.00 | 11% 93.03K to 103.03K | |
| 24-May-24 10:00 PM View: | Ptc Therapeutics, Inc. (PTCT) | 22-May-24 | Option Exercise | 20,000 | $26.42 | $528,400.00 | 138% 14.5K to 34.5K | |
| 24-May-24 10:00 PM View: | Ptc Therapeutics, Inc. (PTCT) | 22-May-24 | Option Sale | 20,000 | $38.24 | $764,800.00 | (58%) 34.5K to 14.5K | |
| 16-Feb-24 4:10 PM View: | Ptc Therapeutics, Inc. (PTCT) | 15-Feb-24 | Grant | 4,000 | -- | -- | 38% 10.5K to 14.5K | |
| 30-May-23 4:05 PM View: | Nexgel, Inc. (NXGL) | 26-May-23 | Purchase | 5,000 | $2.34 | $11,688.50 | 6% 88.03K to 93.03K | |
| 09-Jan-23 4:16 PM View: | Ptc Therapeutics, Inc. (PTCT) | 05-Jan-23 | Grant | 4,000 | -- | -- | 62% 6.5K to 10.5K | |
| 28-Mar-22 4:07 PM View: | Nexgel, Inc. (NXGL) | 25-Mar-22 | Purchase | 5,300 | $1.89 | $10,010.10 | 6% 82.73K to 88.03K | |
| 11-Jan-22 4:10 PM View: | Ptc Therapeutics, Inc. (PTCT) | 07-Jan-22 | Grant | 3,200 | -- | -- | 97% 3.3K to 6.5K | |
| 03-Jan-22 4:46 PM View: | Nexgel, Inc. (NXGL) | 27-Dec-21 | Purchase | 9,091 | $5.49 | $49,909.60 | 12% 73.64K to 82.73K | |
| 18-May-21 5:00 PM View: | DOR BioPharma, Inc. (SNGX) | 14-May-21 | Market Purchase | 3,000 | $0.89 | $2,664.00 | 13% 22.92K to 25.92K | |
| 18-May-21 5:00 PM View: | DOR BioPharma, Inc. (SNGX) | 14-May-21 | Market Sale | 3,000 | $0.90 | $2,700.60 | (12%) 25.92K to 22.92K | |
| 19-Feb-21 4:30 PM View: | Neximmune, Inc. (NEXI) | 17-Feb-21 | Purchase | 5,882 | $17.00 | $99,994.00 | 100% 0 to 5.88K | |
| 08-Jan-21 5:07 PM View: | Ptc Therapeutics, Inc. (PTCT) | 06-Jan-21 | Grant | 1,650 | -- | -- | 100% 1.65K to 3.3K | |
| 28-May-20 10:58 AM View: | Biosig Technologies, Inc. (BSGM) | 28-May-20 | Market Purchase | 1,000 | $10.49 | $10,488.90 | < 1% 106.94K to 107.94K | (58%) |
| 31-Jan-20 4:44 PM View: | Ptc Therapeutics, Inc. (PTCT) | 29-Jan-20 | Grant | 1,650 | -- | -- | 100% 0 to 1.65K | |
| 19-Nov-19 4:19 PM View: | DOR BioPharma, Inc. (SNGX) | 19-Nov-19 | Market Purchase | 2,000 | $0.93 | $1,850.00 | 10% 20.92K to 22.92K | 44% |
| 23-Sep-19 4:19 PM View: | DOR BioPharma, Inc. (SNGX) | 19-Sep-19 | Market Purchase | 4,000 | $0.94 | $3,740.00 | 24% 16.92K to 20.92K | 44% |
| 22-May-19 5:02 PM View: | Biosig Technologies, Inc. (BSGM) | 22-May-19 | Option Exercise | 21,097 | $3.58 | $75,514.50 | 25% 85.85K to 106.94K | |
| 22-May-19 5:02 PM View: | Biosig Technologies, Inc. (BSGM) | 21-May-19 | Grant | 3,804 | $7.44 | $28,301.80 | 6% 68.71K to 72.51K | (40%) |
| 22-May-19 5:02 PM View: | Biosig Technologies, Inc. (BSGM) | 21-May-19 | Conversion | 13,334 | $3.75 | $50,002.50 | 18% 72.51K to 85.85K | |
| 22-Apr-19 4:41 PM View: | DOR BioPharma, Inc. (SNGX) | 22-Apr-19 | Market Purchase | 10,000 | $0.73 | $7,274.00 | 145% 6.92K to 16.92K | 89% |
| 26-Jun-17 10:05 AM View: | HepaLife Technologies Inc. (ALQA) | 23-Jun-17 | Acquisition (other) | 100,000 | -- | -- | 15% 686.75K to 786.75K | |
| 06-Apr-17 8:00 PM View: | Metastat, Inc. (MTST) | 04-Apr-17 | Purchase | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 01-Mar-17 6:04 AM View: | HepaLife Technologies Inc. (ALQA) | 27-Feb-17 | Market Purchase | 400,000 | $0.50 | $200,000.00 | 139% 286.75K to 686.75K | |
| 03-Feb-17 7:43 PM View: | Quikbyte Software, Inc. (SRNEQ) | 03-Feb-17 | Market Purchase | 10,000 | $5.15 | $51,500.00 | 100% 0 to 10.0K | 86% |
| 23-Dec-15 10:04 AM View: | DOR BioPharma, Inc. (SNGX) | 23-Dec-15 | Market Purchase | 2,500 | $1.27 | $3,175.00 | 4% 66.67K to 69.17K | (88%) |
| 09-Nov-15 11:55 AM View: | HepaLife Technologies Inc. (ALQA) | 06-Nov-15 | Market Purchase | 14,000 | $2.91 | $40,740.00 | 5% 272.75K to 286.75K | |
| 09-Apr-15 6:52 PM View: | DOR BioPharma, Inc. (SNGX) | 09-Apr-15 | Option Exercise | 17,857 | $0.61 | $10,892.80 | 37% 48.81K to 66.67K | |
| 04-Sep-14 11:50 AM View: | HepaLife Technologies Inc. (ALQA) | 03-Sep-14 | Option Exercise | 23,500 | $4.24 | $99,640.00 | 9% 249.25K to 272.75K | |
| 10-Jun-14 2:18 PM View: | HepaLife Technologies Inc. (ALQA) | 06-Jun-14 | Option Exercise | 23,500 | $4.24 | $99,640.00 | 10% 225.75K to 249.25K | |
| 02-Jul-13 2:39 PM View: | HepaLife Technologies Inc. (ALQA) | 28-Jun-13 | Purchase | 8,641,980 | -- | -- | 700% 1.23M to 9.88M | |
| 26-Jun-13 4:18 PM View: | DOR BioPharma, Inc. (SNGX) | 25-Jun-13 | Market Purchase | 23,809 | $1.05 | $24,999.40 | 95% 25.0K to 48.81K | (85%) |
| 24-Jun-13 7:20 PM View: | DOR BioPharma, Inc. (SNGX) | 20-Jun-13 | Option Exercise | 25,000 | $0.30 | $7,500.00 | 100% 0 to 25.0K | 660% |
| 25-Feb-13 2:54 PM View: | HepaLife Technologies Inc. (ALQA) | 22-Feb-13 | Purchase | 1,234,570 | -- | -- | 100% 0 to 1.23M |